Mediaiplus
PrivateLast Round
Pre Seed
Nov 1, 2024
Total Funding Raised
$785,000
Company Overview
Mediaiplus is a healthcare technology company that provides an AI-powered clinical trial data platform and CRO matching services to pharmaceutical, biotech, and medical device companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Medical AI, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Marketplace Commission, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mediaiplus Comparables
Compare Mediaiplus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Risklick AG | 78% | |
| ZS | 73% | |
| SyneticX | 72% | |
Mediaiplus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Nov 1, 2024 | ||||
| Grant | Jul 27, 2022 | ||||
| Seed | Dec 21, 2020 | ||||
| Accelerator | Feb 5, 2020 |
Mediaiplus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Seed |
| Bluepoint Partners | Accelerator |
| Hanyang University Technology Holdings | Seed |
| Ministry of Science and ICT of South Korea | Grant |
| KingoSpring | Seed |
Mediaiplus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mediaiplus's valuation, stock price, and market status.